Rombouts; Geert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rombouts; Geert.The latest application filed is for "cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis b".

Company Profile

8.8.13

Rombouts; Geert - Borsbeek BE
ROMBOUTS; Geert - Barsbeek BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B Grant 11,078,193 - Vandyck , et al. August 3, 2	2021-08-03
Cyclized Sulfamoylarylamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20210179635 - VENDEVILLE; Sandrine Marie Helene ; et al.	2021-06-17
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B Grant 10,995,064 - Vandyck , et al. May 4, 2	2021-05-04
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20210024462 - VANDYCK; Koen ; et al.	2021-01-28
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B Grant 10,875,876 - Vendeville , et al. December 29, 2	2020-12-29
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20200255373 - Kind Code	2020-08-13
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B Grant 10,676,429 - Vandyck , et al.	2020-06-09
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20200039931 - VANDYCK; Koen ; et al.	2020-02-06
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B Grant 10,457,638 - Vandyck , et al. Oc	2019-10-29
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B Grant 10,450,270 - VanDyck , et al. Oc	2019-10-22
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20180141905 - VANDYCK; Koen ; et al.	2018-05-24
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20180127361 - VANDYCK; Koen ; et al.	2018-05-10
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B Grant 9,884,818 - Vandyck , et al. February 6, 2	2018-02-06
Cyclized Sulfamoylarylamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20170002025 - VENDEVILLE; Sandrine Marie Helene ; et al.	2017-01-05
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20160347741 - VANDYCK; Koen ; et al.	2016-12-01
Glyoxamide Substituted Pyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20160176817 - VANDYCK; Koen ; et al.	2016-06-23
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20160115125 - VANDYCK; Koen ; et al.	2016-04-28
4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B Grant 9,233,933 - Vandyck , et al. January 12, 2	2016-01-12
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20150274653 - Vandyck; Koen ; et al.	2015-10-01
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20150266890 - Vandyck; Koen ; et al.	2015-09-24
4,4-disubstituted-1,4-dihydropyrimidines And The Use Thereof As Medicaments For The Treatment Of Hepatitis B App 20150005295 - Vandyck; Koen ; et al.	2015-01-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.